Insulin-like growth factor (IGF)-1 is increased in different models of
acute lung injury, and is an important determinant of survival and proliferation in many cells. We previously demonstrated that treatment of mice with
IGF-1 receptor-blocking antibody (A12) improved early survival
in bleomycin-induced
lung injury. We have now examined whether administration of A12 improved markers of
lung injury in
hyperoxia model of
lung injury. C57BL/6 mice underwent intraperitoneal administration of A12 or control antibody (
keyhole limpet hemocyanin [KLH]), then were exposed to 95%
hyperoxia for 88-90 hours. Mice were killed and bronchoalveolar lavage (BAL) and lung tissue were obtained for analysis.
Hyperoxia caused a significant increase in IGF levels in BAL and lung lysates. Peripheral blood neutrophils expressed IGF-1R at baseline and after
hyperoxia. BAL neutrophils from
hyperoxia-treated mice and patients with
acute lung injury also expressed cell surface IGF-1R. A12-treated mice had significantly decreased polymorphonuclear cell (PMN) count in BAL compared with KLH control mice (P = 0.02). BAL from A12-treated mice demonstrated decreased PMN chemotactic activity compared with BAL from KLH-treated mice. Pretreatment of PMNs with A12 decreased their chemotactic response to BAL from
hyperoxia-exposed mice. Furthermore,
IGF-1 induced a dose-dependent chemotaxis of PMNs. There were no differences in other
chemotactic cytokines in BAL, including CXCL1 and CXCL2. In summary, IGF blockade decreased PMN recruitment to the alveolar space in a mouse model of
hyperoxia. Furthermore, the decrease in BAL PMNs was at least partially due to a direct effect of A12 on PMN chemotaxis.